About
Anti-virals
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
1,471
By Phase
PHASE2: 5PHASE2/PHASE3: 1NA: 1PHASE3: 1PHASE1: 3
By Status
COMPLETED: 8UNKNOWN: 1WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04298060Lead Sponsor
DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
PHASE2Unknown
280 participants
Started: Jul 31, 2020 · Completed: Sep 30, 2022
NCT04354389Lead Sponsor
DAS181 for STOP COVID-19
PHASE2/PHASE3Withdrawn
Started: Jul 25, 2020 · Completed: Nov 30, 2020
NCT04324489Collaborator
DAS181 for Severe COVID-19: Compassionate Use
NACompleted
4 participants
Started: Mar 6, 2020 · Completed: Apr 30, 2020
NCT03808922Lead Sponsor
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
PHASE3Recruiting
274 participants
Started: May 23, 2019 · Completed: Aug 31, 2025
NCT01644877Lead Sponsor
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
PHASE2Completed
111 participants
Started: Mar 31, 2014 · Completed: Dec 15, 2016
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...